Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Copper/zinc superoxide dismutase, nuclear DNA content, and progression in human gliomas.

Yoshii Y, Saito A, Zhao DW, Nose T.

J Neurooncol. 1999 Apr;42(2):103-8.

PMID:
10421066
2.

Expression of enzymes and oncogene induced after radiotherapy and/or chemotherapy in patients with brain tumors.

Yoshii Y, Saito A, Hyodo A, Tsurushima H, Sun L.

Hum Cell. 2001 Mar;14(1):95-103.

PMID:
11436358
3.

Nuclear morphometry and DNA densitometry of human gliomas by image analysis.

Yoshii Y, Saito A, Nose T.

J Neurooncol. 1995 Oct;26(1):1-9.

PMID:
8583239
4.

Nuclear characterization and G2M ploidy in human brain tumors using semiautomated image analysis.

Yoshii Y, Saito A, Tsuboi K, Tsurushima H, Komatsu Y, Tomono Y, Hyodo A, Nose T.

Noshuyo Byori. 1995 Mar;12(1):61-7.

PMID:
7795731
5.

Clonal analysis of gliomas.

Kattar MM, Kupsky WJ, Shimoyama RK, Vo TD, Olson MW, Bargar GR, Sarkar FH.

Hum Pathol. 1997 Oct;28(10):1166-79.

PMID:
9343324
6.

p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression.

van Meyel DJ, Ramsay DA, Casson AG, Keeney M, Chambers AF, Cairncross JG.

J Natl Cancer Inst. 1994 Jul 6;86(13):1011-7.

PMID:
8007011
7.

Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas.

Zhen HN, Zhang X, Hu PZ, Yang TT, Fei Z, Zhang JN, Fu LA, He XS, Ma FC, Wang XL.

Cancer. 2005 Dec 15;104(12):2775-83.

8.

Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression.

Reifenberger J, Ring GU, Gies U, Cobbers L, Oberstrass J, An HX, Niederacher D, Wechsler W, Reifenberger G.

J Neuropathol Exp Neurol. 1996 Jul;55(7):822-31.

PMID:
8965097
9.

Flow-cytophotometry of nuclear DNA in biopsies of 45 human gliomas and after primary culture in vitro.

Spaar FW, Ahyai A, Spaar U, Gazsó L, Zimmermann A.

Clin Neuropathol. 1986 Jul-Aug;5(4):157-75.

PMID:
3757347
10.

Age and bromodeoxyuridine labelling index as prognostic factors in high-grade gliomas treated with surgery and radiotherapy.

Gasinska A, Skolyszewski J, Glinski B, Niemiec J, Adamczyk A, Krzyszkowski T, Zabek M.

Clin Oncol (R Coll Radiol). 2006 Aug;18(6):459-65.

PMID:
16909969
11.

Malignant gliomas--ploidy and DNA-content before and after therapy.

Pilichowska ME, Schröter P, Haug BA, Krygier-Stojalowska A.

Zentralbl Pathol. 1994 Jul;140(2):155-60.

PMID:
7947621
12.

Expression and significance of urokinase type plasminogen activator gene in human brain gliomas.

Zhang X, Fei Z, Bu X, Zhen H, Zhang Z, Gu J, Chen Y.

J Surg Oncol. 2000 Jun;74(2):90-4.

PMID:
10914816
13.

Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease.

Kruidenier L, Kuiper I, van Duijn W, Marklund SL, van Hogezand RA, Lamers CB, Verspaget HW.

J Pathol. 2003 Sep;201(1):7-16.

PMID:
12950012
14.

Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.

Server A, Kulle B, Gadmar ØB, Josefsen R, Kumar T, Nakstad PH.

Eur J Radiol. 2011 Nov;80(2):462-70. doi: 10.1016/j.ejrad.2010.07.017. Epub 2010 Aug 13.

PMID:
20708868
15.

Superoxide dismutases in the human colorectal cancer sequence.

Janssen AM, Bosman CB, Kruidenier L, Griffioen G, Lamers CB, van Krieken JH, van de Velde CJ, Verspaget HW.

J Cancer Res Clin Oncol. 1999;125(6):327-35.

PMID:
10363564
16.

Prognostic relevance of cell proliferation markers and DNA-ploidy in gliomas.

Struikmans H, Rutgers DH, Jansen GH, Tulleken CA, van der Tweel I, Battermann JJ.

Acta Neurochir (Wien). 1998;140(2):140-7.

PMID:
10398993
17.

[Role of Zn, Cu--trace elements and superoxide dismutase (SOD) in oxidative stress progression in chronic venous insufficiency (CVI)].

Krzyściak W, Kózka M, Kowalska J, Kwiatek WM.

Przegl Lek. 2010;67(7):446-9. Polish.

PMID:
21387752
18.

Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas.

Wang XB, Tian XY, Li Y, Li B, Li Z.

J Neurooncol. 2012 Jan;106(1):43-51. doi: 10.1007/s11060-011-0640-3. Epub 2011 Jul 3.

PMID:
21725855
19.

Cytogenetic and flow cytometry DNA analysis of regional heterogeneity in a low grade human glioma.

Coons SW, Johnson PC, Shapiro JR.

Cancer Res. 1995 Apr 1;55(7):1569-77.

20.

Supplemental Content

Support Center